Prospects for future advancements in islet cell transplantation

Minerva Chirurgica

Volumn 64, Issue 1, 2009, Pages 59-73

  Sabek, O M ^a,b   Hamilton, D J ^b   Gaber, A O ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Diabetes mellitus; Islets of langerhans transplantation; Pancreatectomy; Type 1

Indexed keywords

EID: 67650260655     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (112)

1. Markmann JF, Deng S, Desai NM, Huang X, Velidedeoglu E, Frank A et al. The use of non-heart- beating donors for isolated pancreatic islet transplantation. Transplantation 2003;75:1423-9.
2. Liu X, Matsumoto S, Okitsu T, Iwanaga Y, Noguchi H, Yonekawa Y et al. Analysis of donor- and isolation- related variables from non-heart-beating donors (NHBDs) using the Kyoto islet isolation method. Cell Transplant 2008;17:649-56.
3. Iwanaga Y, Sutherland DE, Harmon JV, Papas KK. Pancreas preservation for pancreas and islet transplantation. Curr Opin Organ Transplant 2008;13:135-41.
4. Baertschiger RM, Berney T, Morel P. Organ preservation in pancreas and islet transplantation. Curr Opin Organ Transplant 2008;13:59-66.
5. Andrades P, Asiedu CK, Gansuvd B, Inusah S, Goodwin KJ, Deckard LA et al. Pancreatic islet isolation variables in non-human primates (rhesus macaques). Diabetologia 2008;51:1236-44.
6. Hanley SC, Paraskevas S, Rosenberg L. Donor and isolation variables predicting human islet isolation success. Transplantation 2008;85:950-5.
7. Sabek OM, Cowan P, Fraga DW, Gaber AO. The effect of donor factors on human islet yield and their in vivo function. Prog Transplant 2006;16:350-4.
8. Ponte GM, Pileggi A, Messinger S, Alejandro A, Ichii H, Baidal DA et al. Toward maximizing the success rates of human islet isolation: influence of donor and isolation factors. Cell Transplant 2007;16:595-607.
9. Sabek OM, Cowan P, Fraga D, Gaber AO. The Effect of Isolation Methods and the Use of Different Enzymes on Islet Yield and In Vivo Function. Cell Transplantation 2008;17:785-92.
10. Sabek OM, Troung L, Peterson L, Fraga D, Gaber AO. The impact of donor, procurement, and isolation factors on pancreatic islet purity, and integrity. International Transplant meeting. Sydney, Australia August 2008.
11. Rosendale JD, Kauffman HM, McBride MA, Chabalewski FL, Zaroff JG, Garrity ER et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003;75:482-7.
12. Mahler R, Franke FE, Hering BJ, Brandhorst D, Brandhorst H, Brendel MD et al. Evidence for a significant correlation of donor pancreas morphology and the yield of isolated purified human islets. J Mol Med 1999;77:87-9.
13. Lakey JR, Helms LM, Kin T, Korbutt GS, Rajotte RV, Shapiro AM et al. Serine-protease inhibition during islet isolation increases islet yield from human pancreases with prolonged ischemia. Transplantation 2001;72:565-70.
14. Brandhorst H, Brandhorst D, Hering BJ, Federlin K, Bretzel RG. Body mass index of pancreatic donors: a decisive factor for human islet isolation. Exp Clin Endocrinol Diabetes 1995;103(Suppl 2):23-6.
15. Matsumoto S, Qualley SA, Goel S, Hagman DK, Sweet IR, Poitout V et al. Effect of the two-layer (University of Wisconsin solution- perfluorochemical plus 02) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol. Transplantation 2002;74:1414-9.
16. Kim SC, Han DJ, Kang CH, We YM, Back JH, Kim YH et al. Analysis on donor and isolation-related factors of successful isolation of human islet of Langerhans from human cadaveric donors. Transplant Proc 2005;37:3402- 3.
17. Sabek OM, Peterson L, Troung L, Fraga D, Gaber AO. A Significant Correlation of Donor Pancreas Morphology and Islet Function. ATC, Toronto, Canada 2008; May 31-Jun e4.
18. Matsumoto S, Zhang G, Qualley S, Clever J, Tombrello Y, Strong DM et al. Analysis of donor factors affecting human islet isolation with current isolation protocol. Transplant Proc 2004;36:1034-6.
19. Benhamou PY, Watt PC, Mullen Y, Ingles S, Watanabe Y, Nomura Y et al. Human islet isolation in 104 consecutive cases. Factors affecting isolation success. Transplantation 1994;57:1804-10.
20. Larsson H, Ahren B. Islet dysfunction in obese women with impaired glucose tolerance. Metabolism 1996;45:502-9.
21. Larsson H, Berglund G, Ahren B. Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance. J Clin Endocrinol Metab 1995;80:1778-82.
22. Sabek OM, Marshall DR, Minora O, Fraga DW, Gaber AO. OP-142 gene expression profile of nonfunctional human pancreatic islets: predictors of transplant failure? Transplant Proc 2005;37:3441-3.
23. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
24. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003;52:102-10.
25. Bogardus C, Lillioja S, Howard BV, Reaven G, Mott D. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 1984;74:1238-46.
26. Weyer C, Bogardus C, Mott DM, Pradey RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mel- litus. J Clin Invest 1999;104:787-94.
27. Wajchenberg BL. beta-cell failure in diabetes and preservation by clinical treatment. Endocrine reviews 2007;28:187-218.
28. Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, Perren A, Ehses JA. Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 2008;3KSuppl 2):Sl6l-l64.
29. Gerich JE. Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clinic Proceedings 2003;78447- 56.
30. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstom RW, Fujimoto WY. Proinsulin levels predict the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japanese-American men. Diabet Med 1996;13(9 Suppl 6):S63-66.
31. Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocrine reviews 2008;29:42-61.
32. Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 2003;52:581-7.
33. Donath MY, Halban PA. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 2004;47:581-9.
34. Harding HP, Ron D. Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes 2002;51(Suppl 3):S455-46l.
35. Grill V, Bjorklund A. Overstimulation and beta-cell function. Diabetes 2001;50(Suppl 1):S122-124.
36. Newsholme P, Haber EP, Hirabara SM, Rebelato EL, Procopio J, Morgan D et al. Diabetes associated cell stress and dysfunction: role of mitochondrial and non- mitochondrial ROS production and activity. J Physiol 2007;583(Pt l):9-24.
37. Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 2003;52:726-33.
38. Summers SA. Ceramides in insulin resistance and lipo- toxicity. Progress in lipid research 2006;45:42-72.
39. Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocrine reviews 2008;29:351-66.
40. Lakey JR, Warnock GL, Rajotte RV, Suarez-Alamazor ME, Ao Z, Shapiro AM etal. Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation 1996;61:1047-53.
41. Toso C, Oberholzer J, Ris F, Triponez F, Bucher P, Demirag A et al. Factors affecting human islet of Langerhans isolation yields. Transplant Proc 2002;34:826-7.
42. Heikes KE, Eddy DM, Arondekar B, Schlessinger L. Diabetes risk calculator: a simple tool for detecting undiagnosed diabetes and pre-diabetes. Diabetes Care 2008;31:1040-5.
43. Abdul-Ghani MA, Matsuda M, Jani R, Jenkinson CP, Coletta DK, Kaku K et al. The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance. Am J Physiol Endocrinol Metab 2008;295:E401-406.
44. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
45. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki- Jarvinen H, Van Haeften T et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295-301.
46. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-70.
47. Teuscher AU, Kendall DM, Smets YF, Leone JP, Sutherland DE, Robertson RP. Successful islet auto- transplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes 1998;47:324-30.
48. Nath DS, Kellogg TA, Sutherland DE. Total pancreatectomy with intraportal auto-islet transplantation using a temporarily exteriorized omental vein. J Am Coll Surg 2004;199:994-5.
49. Webb MA, Illouz SC, Pollard CA, Gregory R, Mayberry JF, Tordoff SG et al. Islet auto transplantation following total pancreatectomy: a long-term assessment of graft function. Pancreas 2008;37:282-7.
50. Kuroda Y, Fujino Y, Morita A, Tanioka Y, Ku Y, Saitoh Y. Oxygenation of the human pancreas during preservation by a two-layer (University of Wisconsin solution/perfluorochemical) cold-storage method. Transplantation 1992;54:561-2.
51. Kuroda Y, Fujino Y, Kawamura T, Suzuki Y, Fujiwara H, Saitoh Y. Mechanism of oxygenation of pancreas during preservation by a two-layer (Euro-Collins' solu- tion/perfluorochemical) cold-storage method. Transplantation 1990;49:694-6.
52. Lakey JR, Tsujimura T, Shapiro AM, Kuroda Y. Preservation of the human pancreas before islet isolation using a two-layer (UW soluuon-perfluorochemical) cold storage method. Transplantation 2002;74:1809- 11.
53. Ricordi C, Fraker C, SzustJ, Al-Abdullah I, Poggioli R, Kirlew T et al. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation 2003;75:1524-7
54. Ibid
55. Tsujimura T, Kuroda Y, Avila JG, Kin T, Oberholzer J, Shapiro AM etal. Influence of pancreas preservation on human islet isolation outcomes: impact of the two-layer method. Transplantation 2004;78:96-100.
56. Brandhorst H, Muehling B, Yamaya H, Henriksnaes J, Carlsson PO, Korsgren O etal. New class of oxygen carriers improves islet isolation from long-term stored rat pancreata. Transplant Proc 2008;40:393-4.
57. Goto T, Tanioka Y, Sakai T, Terai S, Kamoda Y, Li S et al. Application of the two-layer method on pancreas digestion results in improved islet yield and maintained viability of isolated islets. Transplantation 2007;83:754- 8.
58. Matsumoto S, Rigley TH, Reems JA, Kuroda Y, Stevens RB. Improved islet yields from Macaca nemestrina and marginal human pancreata after two-layer method preservation and endogenous trypsin inhibition. Am J Transplant 2003;3:53-63.
59. Lee TC, Barshes NR, Brunicardi FC, Alejandro R, Ricordi C, Nguyen L et al. Procurement of the human pancreas for pancreatic islet transplantation. Transplantation 2004;78:481-3.
60. Guignard AP, Oberholzer J, Benhamou PY, Touzet S, Bucher P, Penfornis A et al. Cost analysis of human islet transplantation for the treatment of type 1 diabetes in the Swiss-French Consortium GRAGIL. Diabetes Care 2004;27:895-900.
61. Huang GC, Zhao M, Jones P, Persaud S, Ramracheya R, Lobner K et al. The development of new density gradient media for purifying human islets and islet-quality assessments. Transplantation 2004;77:143-5.
62. Nano R, Clissi B, Melzi R, Calori G, Maffi P, Antonioli B et al. Islet isolation for allotransplantation: variables associated with successful islet yield and graft function. Diabetologia 2005;48:906-12.
63. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 1988;37:413-20.
64. Robertson GS, Chadwick DR, Contractor H, James RF, Bell PR, London NJ. The use of continuous density gradients for the assessment of islet and exocrine tissue densities and islet purification. Acta Diabetol 1993;30:175-80.
65. Jansson L. The regulation of pancreatic islet blood flow. Diabetes Metab Rev 1994;10:407-16.
66. Parr EL, Bowen KM, Lafferty KJ. Cellular changes in cultured mouse thyroid glands and islets of Langerhans. Transplantation 1980;30:135-41.
67. Cross SE, Hughes SJ, Partridge CJ, Clark A, Gray DW, Johnson PR. Collagenase penetrates human pancreatic islets following standard intraductal administration. Transplantation 2008;86:907-11.
68. O'Gorman D, Kin T, McGhee-Wilson D, Shapiro AM, Lakey JR. Multi-lot analysis of custom collagenase enzyme blend in human islet isolations. Transplant Proc 2005;37:3417-9.
69. Bucher P, Mathe Z, Morel P, Bosco D, Andres A, Kurfuest M et al. Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation. Transplantation 2005;79:91-7.
70. Bucher P, Mathe Z, Bosco D, Andres A, Kurfuerst M, Ramsch-Gunther N et al. Serva collagenase NB1: a new enzyme preparation for human islet isolation. Transplant Proc 2004;36:1143-4.
71. Antonioli B, Fermo I, Cainarca S, Marzorati S, Nano R, Baldissera M et al. Characterization of collagenase blend enzymes for human islet transplantation. Transplantation 2007;84:1568-75.
72. Robertson GS, Chadwick DR, Contractor H, James RF, London NJ. The optimization of large-scale density gradient isolation of human islets. Acta Diabetol 1993;30:93-8.
73. van der Burg MP, Guicherit OR, Frolich M, Prins FA, Bruijn JA, Gooszen HG. Cell preservation in University of Wisconsin solution during isolation of canine islets of Langerhans. Cell Transplant 1994;3:315-24.
74. London NJ, Toomey P, Contractor H, Thirdborough ST, James RF, Bell PR. The effect of osmolality and glucose concentration on the purity of human islet isolates. Transplant Proc 1992;24:1002.
75. Pretlow TG, 2nd, weir EE, Zettergren JG. Problems connected with the separation of different kinds of cells. International review of experimental pathology 1975;14:91-204.
76. Schwartz BD, Traverso LW. Morphological changes in pancreatic fragments prepared for transplantation by collagenase treatment. Transplantation 1984;38:273-80.
77. Burg MB, Grollman EF, Orloff J. Sodium and Potassium Flux of Separated Renal Tubules. The American journal of physiology 1964;206:483-91.
78. Ichii H, Pileggi A, Molano RD, Baidal DA, Khan A, Kuroda Y et al. Rescue purification maximizes the use of human islet preparations for transplantation. Am J Transplant 2005;5:21-30.
79. Kessler L, Bucher P, Milliat-Guittard L, Benhamou PY, Berney T, Penfornis A et al. Influence of islet transportation on pancreatic islet allotransplantation in type 1 diabetic patients within the Swiss-French GRAGIL network. Transplantation 2004;77:1301-4.
80. Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Sokes G et al. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center. Transplantation 2002;74:1761-6.
81. MacKenzie DA, Sollinger HW, Hullett DA. Removal of CD45+ cells from human fetal pancreas alters immuno- genicity in vitro. Transplant Proc 2003;35:1506-7.
82. Scharp DW, Lacy PE, Finke E, Olack B. Low-temperature culture of human islets isolated by the distention method and purified with Ficoll or Percoll gradients. Surgery 1987;102:869-79.
83. Sabek OM, Marshall DR, Penmetsa R, Scarborough O, Gaber AO. Examination of gene expression profile of functional human pancreatic islets after 2-week culture. Transplant Proc 2006;38:3678-9.
84. A comparison of media supplement methods for the extended culture of human islet tissue.PG - 1060-6. Transplantation 1998;65:1060-6.
85. Gaber AO, Fraga DW, Callicutt CS, Gerling IC, Sabek OM, Kotb MY. Improved in vivo pancreatic islet function after prolonged in vitro islet culture. Transplantation 2001;72:1730-6.
86. Rush BT, Fraga DW, Kotb MY, Sabek OM, Lo A, Gaber LW et al. Preservation of human pancreatic islet in vivo function after 6-month culture in serum-free media. Transplantation 2004;77:1147-54.
87. Cattan P, Berney T, Schena S, Molano RD, Pileggi A, Vizzardelli C et al. Early assessment of apoptosis in isolated islets of Langerhans. Transplantation 2001;71:857- 62.
88. Caulin-GlaserT, Watson CA, Pardi R, Bender JR. Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 1996;98:36-42.
89. Lacy PE, Davie JM, Finke EH. Prolongation of islet allograft survival following in vitro culture (24 degrees C) and a single injection of ALS. Science 1979;204:312-3.
90. Schmied BM, Ulrich A, Matsuzaki H, Ding X, Ricordi C, Weide L et al. Transdifferentiation of human islet cells in a long-term culture. Pancreas 2001;23:157-71.
91. Schmied BM, Ulrich A, Matsuzaki H, Ding X, Ricordi C, Moyer MP et al. Maintenance of human islets in long-term culture. Differentiation 2000;66:173-80.
92. Buitrago A, Gylfe E. Significance of serum for the preservation of insulin secretion during culture. Med Biol 1983;61:133-8.
93. Yuan S, Rosenberg L, Paraskevas S, Agapitos D, Duguid WP. Transdifferentiation of human islets to pancreatic ductal cells in collagen matrix culture. Differentiation 1996;61:67-75.
94. Wang J, Zhang X. Needle-type dual microsensor for the simultaneous monitoring of glucose and insulin. Anal Chem 2001;73:844-7.
95. Thomas FT, Contreras JL, Bilbao G, Ricordi C, Curiel D, Thomas JM. Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation. Surgery 1999;126:299-304.
96. Rutzky LP, Bilinski S, Kloc M, Phan T, Zhang H, Katz SM et al. Microgravity culture condition reduces immunogenicity and improves function of pancreatic isletsl. Transplantation 2002;74:13-21.
97. Seattle GM, Montgomery AM, Lopez AD, Hao E, Perez B, Just ML et al. A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes 2002;51:3435-9.
98. Contreras JL, Smyth CA, Bilbao G, Young CJ, Thompson JA, Eckhoff DE. 17beta-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality. Transplantation 2002;74:1252-9.
99. Sabek OM, Fraga DW, Henry J, Gaber LW, Kotb M, Gaber AO. Expression of transforming growth factor- beta by human islets: impact on islet viability and function. Cell Transplant 2007;16:775-85.
100. Beattie GM, Cirulli V, Lopez AD, Hayek A. Ex vivo expansion of human pancreatic endocrine cells. J Clin Endocrinol Metab 1997;82:1852-6.
101. Beattie GM, Rubin JS, Mally MI, Otonkoski T, Hayek A. Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact. Diabetes 1996;45:1223-8.
102. Otonkoski T, Beattie GM, Rubin JS, Lopez AD, Baird A, Hayek A. Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes 1994;43:947-53-
103. Dionne KE, Colton CK, Yarmush ML. Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes 1993;42:12-21.
104. Caiazzo R, Gmyr V, Kremer B, Hubert T, Soudan B, Lukowiak B et al. Quantitative in vivo islet potency assay in normoglycemic nude mice correlates with primary graft function after clinical transplantation. Transplantation 2008;86:360-3.
105. Gerling IC, Kotb M, Fraga D, Sabek O, Gaber AO. No correlation between in vitro and in vivo function of human islets. Transplant Proc 1998;30:587-8.
106. Sweet IR, Gilbert M, Jensen R, Sabek O, Fraga DW, Gaber AO et al. Glucose stimulation of cytochrome C reduction and oxygen consumption as assessment of human islet quality. Transplantation 2005;80:1003-11.
107. Sabek OM, Fraga DW, Minoru O, McClaren JL, Gaber AO. Assessment of human islet viability using various mouse models. Transplant Proc 2005;37:3415-6.
108. Dobson T, Fraga D, Saba C, Bryer-Ash M, Gaber AO, Gerling IC. Human pancreatic islets transfected to produce an inhibitor of TNF are protected against destruction by human leukocytes. Cell Transplant 2000;9:857-65.
109. Sabek OM, Marshall DR, Minoru O, Fraga DW, Gaber AO. Gene expression profile of nonfunctional human pancreatic islets: predictors of transplant failure? Transplant Proc 2005;37:3441-3.
110. Gaber AO, Fraga D, Kotb M, Lo A, Sabek O, Latif K. Human islet graft function in NOD-SCID mice predicts clinical response in islet transplant recipients. Transplant Proc 2004;36:1108-10.
111. Narang AS, Sabek O, Gaber AO, Mahato RI. Co- expression of vascular endothelial growth factor and interleukin-1 receptor antagonist improves human islet survival and function. Pharm Res 2006;23:1970- 82.
112. Narang AS, Cheng K, Henry J, Zhang C, Sabek O, Fraga D et al. Vascular endothelial growth factor gene delivery for revascularization in transplanted human islets. Pharm Res 2004;21:15-25.